Work

Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy.

Year: 1999
Type: article
Source: PubMed
Language: English
Open Access status: closed
OpenAlex ID: W2172077728
FWCI: 1.437
Cites: 40
Cited by: 75
Related to: 10